Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery

Published:2020-01 Issue:1 Volume:25 Page:150-159
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Liu Qiaoyu,Guan Jian,Qin Lu,Zhang Xin,Mao Shirui

Funder

Major Scientific and Technological Special Projects of National ‘Major New Drug Discovery’ of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference103 articles.

1. Clinical perspectives on pulmonary systemic and macromolecular delivery;Scheuch;Adv. Drug Deliv. Rev.,2006

2. Recent advances in controlled pulmonary drug delivery;Lang;Drug Discov. Today,2015

3. Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease;Shirley;Drugs,2019

4. Nanotechnology approaches for inhalation treatment of lung diseases;Kuzmov;J. Control. Release,2015

5. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation;Schneider;Sci. Adv.,2017

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

2. Interpretable Causal System Optimization Framework for the Advancement of Biological Effect Prediction and Redesign of Nanoparticles;Journal of the American Chemical Society;2024-08-01

3. Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis;Journal of Controlled Release;2024-07

4. Impact of the diseased lung microenvironment on the in vivo fate of inhaled particles;Drug Discovery Today;2024-07

5. Enhancing in situ cancer vaccines using delivery technologies;Nature Reviews Drug Discovery;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3